Flexion Therapeutics

$10.90
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.21 (-1.89%) As of 2:25 PM EDT today
-$0.21 (-1.89%) Today

Why Robinhood?

You can buy or sell FLXN and other stocks, options, ETFs, and crypto commission-free!

About FLXN

Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. Read More It offers products under the Zilretta brand. The company was founded by Michael D. Clayman and Neil Bodick in 2007 and is headquartered in Burlington, MA.

Employees
272
Headquarters
Burlington, Massachusetts
Founded
2015
Market Cap
423.37M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
608.35K
High Today
$11.47
Low Today
$10.83
Open Price
$11.01
Volume
168.61K
52 Week High
$23.10
52 Week Low
$8.76

Collections

FLXN News

ReutersAug 7

Edited Transcript of FLXN earnings conference call or presentation 6-Aug-19 8:30pm GMT

36

FLXN Earnings

-$1.43
-$0.75
-$0.06
$0.62
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 7, After Hours

More FLXN News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.